Figure 1 Research advances in osteoarthritis management

Slides:

Advertisements

Similar presentations

EULAR OA Trial Bank Study Group Predicting treatment response in subgroups of osteoarthritis patients using individual patient data of worldwide available.

Advertisements

The Effect of Intra-Articular Steroids on Cartilage in Knee Osteoarthritis.

of different experimental arthritis models

Figure 3 Metabolism in homeostatic chondrocytes

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 4 The mechanistic link between the epithelial-to-mesenchymal

Figure 1 Structure of TNF antagonists

Figure 1 Induction of immune tolerance

Figure 3 Methods to detect trough levels of therapeutic antibodies

Figure 2 Assays for detecting antidrug antibodies to TNF inhibitors

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 5 Defects in the JAK–STAT signalling pathway

EULAR OA Trial Bank Study Group Predicting treatment response in subgroups of osteoarthritis patients using individual patient data of worldwide available.

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Therapeutic targeting of the PI3K/AKT/mTOR pathway

Figure 7 Defects in apoptosis

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Location of HLA variants known to be associated

Figure 3 Defects in the T cell receptor signalling pathway

Figure 4 Altered metabolism in chondrocytes in osteoarthritis

Figure 3 Strategies to achieve therapeutic inhibition of IL-1

Nat. Rev. Urol. doi: /nrurol

Figure 1 Therapeutic targeting of the B-cell receptor (BCR)

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 5 Drugs that target WNT signalling

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 The two-compartment model of body composition

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Age-related changes in TGFβ signalling in articular cartilage

Figure 3 Bone marrow lesions in osteoarthritis

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 5 The mechanism underlying epithelial-to-mesenchymal

Figure 1 Overview of biosimilar product development

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 4 Role of TGFβ in a normal and an osteoarthritic joint

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Inflammatory mechanisms in tendinopathy

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Osteoarthritis and Cartilage

OARSI recommendations for the management of hip and knee osteoarthritis: the semantics of differences and changes T.E. McAlindon, R.R. Bannuru Osteoarthritis.

Figure 1 Principles for the diagnosis and management of osteoarthritis

Intra-articular corticosteroids may be a cost-effective strategy for short-term management of knee osteoarthritis R.R. Bannuru, J.B. Wong, D.M. Kent,

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Transmission of pain by NGF

Anti-inflammatory Properties of SM04690, a Small Molecule Inhibitor of the Wnt Pathway as a Potential Treatment for Knee Osteoarthritis V. Deshmukh,

The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater.

Targeting Cancer Stemness in the Clinic: From Hype to Hope

Figure 2 A model of TNFR–complex I signalling

Figure 4 The complement drug development pipeline

Shifted from Wnt to Hedgehog Signaling Pathways

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Differential response of placebo treatments in osteoarthritis trials: a systematic review and network meta-analysis R.R. Bannuru, C.H. Schmid, M.C. Sullivan,

Figure 2 Phenotypes of osteoarthritis

Figure 2 Proposed approach to treating myositis-associated interstitial lung disease Figure 2 | Proposed approach to treating myositis-associated interstitial.

Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis R.R. Bannuru, N.S. Natov, U.R. Dasi,

Osteoarthritis and Cartilage

Figure 1 Patterns of joint and organ involvement in rheumatic disease

The Ballet of Morphogenesis

Figure 2 The main effects of adipokines on bone remodelling in osteoarthritis Figure 2 | The main effects of adipokines on bone remodelling in osteoarthritis.

Nat. Rev. Rheumatol. doi: /nrrheum

Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying treatment for knee osteoarthritis J.D. Hood, V.

Nat. Rev. Rheumatol. doi: /nrrheum

EULAR OA Trial Bank Study Group Predicting treatment response in subgroups of osteoarthritis patients using Individual Patient Data of worldwide available.

Nat. Rev. Rheumatol. doi: /nrrheum

Presentation transcript:

Figure 1 Research advances in osteoarthritis management Figure 1 | Research advances in osteoarthritis management. A novel drug-delivery system can prolong the analgesic effect of intra-articular glucocorticoids for knee osteoarthritis (OA). Results of clinical trials shed light on the long-term effects of intra-articular glucocorticoids and on the therapeutic potential of a small-molecule inhibitor of the Wnt signalling pathway for OA. Fz, Frizzled; LRP, lipoprotein receptor-related protein. McAlindon, T. E. & Bannuru, R. R. (2018) Latest advances in the management of knee OA Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.219